definiens: has the meaning ascribed to it in Section to it in Section 9.1 . hereof ; ( e ) means the Licen sed Patents, the Material, the CORIXA Research Patents, the Licensed Know -How and the CORIXA Improvements ; ( f ) means any of the three -month periods beginning January 1, April 1, July 1 and October 1 in any year ; ( g ) has the meaning ascribed to it in Section 2.4 . hereof ; -2- 3 ( h ) or means CORIXA 's proprietary antigen of Leishmania, known as lei shmanial eukaryotic initiation factor, either the protein itself or its cDNA ( except as otherwise specified herein ), that is the subject matter of the Licensed Patents ; ( i ) means all patentable or non -patentable inventions, discoveries, technology and information of any type whatsoever, including without limitation compositions, chemical compounds, biological materials, whether or not derived from Material, methods, processes, technical information, knowledge, experience an d know -how which ( i ) utilize, incorporate, derive from, are based on or could not be conceived, developed or reduced to practice but for the use of the CORIXA Technology, ( ii ) which adds to the knowledge of the Material, its properties in general or as an immunoadjuvant for use in vaccines for active immunization or ( iii ) helps mastering or enhancing processes for manufacturing Material ( for instance, in terms of yield or purity ) or processes for formulating Material in combination with other molecules, including but not limited to antigenic proteins ; and which are conceived, developed or reduced to practice as a result of and during the term of the Agreement, solely or jointly by employees or others acting on behalf of CORIXA or by employees or others actin g on behalf of PMC